Yanjun Su

911 total citations
56 papers, 644 citations indexed

About

Yanjun Su is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Yanjun Su has authored 56 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 17 papers in Endocrinology, Diabetes and Metabolism and 14 papers in Surgery. Recurrent topics in Yanjun Su's work include Thyroid Cancer Diagnosis and Treatment (15 papers), Thyroid and Parathyroid Surgery (13 papers) and Lung Cancer Diagnosis and Treatment (9 papers). Yanjun Su is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (15 papers), Thyroid and Parathyroid Surgery (13 papers) and Lung Cancer Diagnosis and Treatment (9 papers). Yanjun Su collaborates with scholars based in China, United States and Germany. Yanjun Su's co-authors include Michael H. Nathanson, Munmun Chakraborty, Roland Baron, Changli Wang, Zhenfa Zhang, Ruochuan Cheng, Changli Wang, Xiubao Ren, Hua Zhao and Jianming Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Yanjun Su

49 papers receiving 634 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanjun Su China 15 288 201 127 120 115 56 644
Abderrahman Ouban Saudi Arabia 11 225 0.8× 147 0.7× 145 1.1× 101 0.8× 81 0.7× 33 554
Wenbin Yu China 15 264 0.9× 183 0.9× 94 0.7× 154 1.3× 161 1.4× 59 584
Eliana Gulotta Italy 13 232 0.8× 184 0.9× 130 1.0× 102 0.8× 163 1.4× 36 673
Qiuxia Cui China 17 414 1.4× 213 1.1× 153 1.2× 190 1.6× 143 1.2× 38 807
Arshad A. Pandith India 14 323 1.1× 139 0.7× 114 0.9× 63 0.5× 112 1.0× 68 604
Sung Sun Kim South Korea 11 244 0.8× 101 0.5× 110 0.9× 168 1.4× 80 0.7× 57 520
Jean‐Nicolas Gallant United States 13 192 0.7× 89 0.4× 155 1.2× 142 1.2× 137 1.2× 43 580
Renfang Xu China 13 362 1.3× 311 1.5× 143 1.1× 148 1.2× 106 0.9× 50 697
Chang-Hsien Lu Taiwan 11 159 0.6× 109 0.5× 174 1.4× 79 0.7× 87 0.8× 15 566
Masato Kitazawa Japan 13 284 1.0× 86 0.4× 163 1.3× 104 0.9× 132 1.1× 69 689

Countries citing papers authored by Yanjun Su

Since Specialization
Citations

This map shows the geographic impact of Yanjun Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanjun Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanjun Su more than expected).

Fields of papers citing papers by Yanjun Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanjun Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanjun Su. The network helps show where Yanjun Su may publish in the future.

Co-authorship network of co-authors of Yanjun Su

This figure shows the co-authorship network connecting the top 25 collaborators of Yanjun Su. A scholar is included among the top collaborators of Yanjun Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanjun Su. Yanjun Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Su, Yanjun, et al.. (2025). Videos on YouTube, Bilibili, TikTok as sources of medical information on Hashimoto’s thyroiditis. Frontiers in Public Health. 13. 1611087–1611087. 1 indexed citations
3.
Wang, Pei, Zhizhong Dong, Yanjun Su, et al.. (2024). Trends of the prevalence rate of central lymph node metastasis and multifocality in patients with low-risk papillary thyroid carcinoma after delayed thyroid surgery. Frontiers in Endocrinology. 15. 1349272–1349272. 3 indexed citations
4.
Liu, Bin, et al.. (2024). Treatment and management of medullary thyroid microcarcinoma: a 10-year retrospective study from a single center. Endocrine. 86(3). 1081–1089. 2 indexed citations
6.
7.
Wang, Xiaodong, et al.. (2022). Identification of Cofilin‐1 as a novel biomarker of atopic dermatitis using iTRAQ quantitative proteomics. Journal of Clinical Laboratory Analysis. 36(11). e24751–e24751. 5 indexed citations
8.
Zhang, Hao, Yanjun Su, Chunze Zhang, et al.. (2022). Phloretin exhibits potential food-drug interactions by inhibiting human UDP-glucuronosyltransferases in vitro. Toxicology in Vitro. 84. 105447–105447. 6 indexed citations
9.
Huang, Chun‐Kai, Mingyao Meng, Shuo Li, et al.. (2022). Umbilical Cord Mesenchymal Stem Cells Ameliorate Kidney Injury in MRL/Ipr Mice Through the TGF-β1 Pathway. Frontiers in Cell and Developmental Biology. 10. 876054–876054. 9 indexed citations
10.
Mao, Ying, et al.. (2021). The role of P62 in the development of human thyroid cancer and its possible mechanism. Cancer Genetics. 256-257. 5–16. 3 indexed citations
11.
Nie, Jing, Shumei Zhang, Peng Wu, Yuangang Liu, & Yanjun Su. (2020). Electrospinning With Lyophilized Platelet-Rich Fibrin Has the Potential to Enhance the Proliferation and Osteogenesis of MC3T3-E1 Cells. Frontiers in Bioengineering and Biotechnology. 8. 595579–595579. 13 indexed citations
12.
Zhang, Qiang, Bin Zhang, Leina Sun, et al.. (2018). Cisplatin resistance in lung cancer is mediated by <italic>MACC1</italic> expression through PI3K/AKT signaling pathway activation. Acta Biochimica et Biophysica Sinica. 50(8). 748–756. 14 indexed citations
13.
Li, Chenguang, Hailin Liu, Bin Zhang, et al.. (2018). Whole-exome sequencing identifies key mutated genes in T790M wildtype/cMET-unamplified lung adenocarcinoma with acquired resistance to first-generation EGFR tyrosine kinase inhibitors. Journal of Cancer Research and Clinical Oncology. 144(6). 1079–1086. 10 indexed citations
14.
Jia, Bin, Changli Wang, Zhenfa Zhang, & Yanjun Su. (2017). Clinical analysis of single- and multiple-port thoracoscopic lobectomy for lung cancer. Clinical Oncology and Cancer Research. 44(9). 440–443. 1 indexed citations
15.
Zhang, Lei, Yanjun Su, Weiran Liu, et al.. (2014). Validation of EORTC QLQ-LC43 for Chinese patients with lung cancer. Lung Cancer. 85(1). 94–98. 12 indexed citations
16.
Yue, Dongsheng, Jian You, Yanjun Su, et al.. (2014). Survival analysis of patients with non-small cell lung cancer who underwent surgical resection following 4 lung cancer resection guidelines. BMC Cancer. 14(1). 422–422. 11 indexed citations
18.
Wang, Changli, Yanjun Su, Lianmin Zhang, et al.. (2012). The Function of SARI in Modulating Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Metastasis. PLoS ONE. 7(9). e38046–e38046. 33 indexed citations
19.
Su, Yanjun. (2010). Study on the action mechanism of protective effects of curcumin on kidney of experimental diabetic rats. 1 indexed citations
20.
Zhao, Hua, Hui Li, Jinpu Yu, et al.. (2010). The Expression of TSLP and Its Relationship with the Number of Infiltrating Regulatory T Cells in Lung Cancer. Clinical Oncology and Cancer Research. 37(3). 126–130.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026